Item Type | Name |
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Lung Neoplasms
|
Concept
|
Lung Diseases
|
Concept
|
Small Cell Lung Carcinoma
|
Concept
|
Lung
|
Academic Article
|
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
|
Academic Article
|
Proton beam therapy and concurrent chemotherapy for esophageal cancer.
|
Academic Article
|
Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.
|
Academic Article
|
Status of particle therapy for lung cancer.
|
Academic Article
|
Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer.
|
Academic Article
|
Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis.
|
Academic Article
|
HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.
|
Academic Article
|
A comparison of tumor motion characteristics between early stage and locally advanced stage lung cancers.
|
Academic Article
|
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
|
Academic Article
|
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.
|
Academic Article
|
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.
|
Academic Article
|
Predictors of postoperative complications after trimodality therapy for esophageal cancer.
|
Academic Article
|
Invited commentary.
|
Academic Article
|
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
|
Academic Article
|
Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation.
|
Academic Article
|
Evaluation of dose variation to normal and critical structures for lung hypofractionated stereotactic body radiation therapy.
|
Academic Article
|
A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer.
|
Academic Article
|
Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.
|
Academic Article
|
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.
|
Academic Article
|
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.
|
Academic Article
|
Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy
|
Academic Article
|
Evaluation of dose variation to normal and critical structures for lung hypofractionated stereotactic body radiation therapy
|
Academic Article
|
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition
|
Academic Article
|
Adjuvant therapy for non-small-cell lung carcinoma following surgical resection
|
Academic Article
|
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition
|
Academic Article
|
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer
|
Academic Article
|
Hsp90 inhibitor ganetespib sensitizes non-small cell lung cancer to radiation but has variable effects with chemoradiation
|
Academic Article
|
Molecular Target Treatment for Personalized Radiotherapy in Lung Cancer
|
Academic Article
|
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.
|
Academic Article
|
Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.
|
Academic Article
|
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
|
Academic Article
|
Improving Outcomes for Esophageal Cancer using Proton Beam Therapy.
|
Academic Article
|
Implications of the Bystander and Abscopal Effects of Radiation Therapy.
|
Academic Article
|
Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
|
Academic Article
|
Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions.
|
Academic Article
|
Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.
|
Academic Article
|
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.
|
Academic Article
|
Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer.
|
Academic Article
|
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
|
Academic Article
|
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.
|
Academic Article
|
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
|
Academic Article
|
Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis.
|
Academic Article
|
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.
|
Academic Article
|
Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.
|
Academic Article
|
Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer.
|
Academic Article
|
Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.
|
Academic Article
|
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
|
Academic Article
|
Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?
|
Academic Article
|
Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.
|
Academic Article
|
Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
|
Academic Article
|
Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer.
|
Academic Article
|
Hematologic variables associated with brain failure in patients with small-cell lung cancer.
|
Academic Article
|
Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer.
|
Academic Article
|
Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
|
Academic Article
|
Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis.
|
Academic Article
|
Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
|
Academic Article
|
The optimal treatment approaches for stage I small cell lung cancer.
|
Academic Article
|
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.
|
Academic Article
|
Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy.
|
Academic Article
|
An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.
|
Academic Article
|
The Role of Adjuvant Radiotherapy for Resected Non-Small Cell Lung Cancer in the Modern Era.
|
Academic Article
|
Evolving Practice Patterns in the Use of Prophylactic Cranial Irradiation for Extensive-Stage Small Cell Lung Cancer.
|
Academic Article
|
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC.
|
Academic Article
|
Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial.
|
Academic Article
|
NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer.
|
Academic Article
|
Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer.
|
Academic Article
|
Metabolic Responses to Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical Trial.
|
Academic Article
|
Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation.
|
Academic Article
|
Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
|
Academic Article
|
Integrating genomic features for non-invasive early lung cancer detection.
|
Academic Article
|
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic.
|
Academic Article
|
Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer.
|
Academic Article
|
Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk Fields.
|
Academic Article
|
Predicting Incomplete Resection in Non-Small Cell Lung Cancer Preoperatively: A Validated Nomogram.
|
Academic Article
|
Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non-Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab.
|
Academic Article
|
Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes.
|
Academic Article
|
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study.
|
Academic Article
|
Authors' Reply to Yajing Du's Letter to the Editor on "Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC".
|
Academic Article
|
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.
|
Academic Article
|
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
|
Academic Article
|
Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.
|
Academic Article
|
Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patients.
|
Academic Article
|
Optimizing current standard of care therapy for stage III non-small cell lung cancer.
|
Academic Article
|
A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer.
|
Academic Article
|
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer.
|
Academic Article
|
Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.
|
Academic Article
|
Cell lines of the same anatomic site and histologic type show large variability in intrinsic radiosensitivity and relative biological effectiveness to protons and carbon ions.
|
Academic Article
|
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study.
|
Academic Article
|
National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non-Small Cell Lung Cancer.
|
Academic Article
|
Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiation Therapy-Induced Cardiotoxicity in Patients with Non-Small Cell Lung Cancer: A Secondary Analysis of a Prospective Randomized Trial.
|
Academic Article
|
High-Content Clonogenic Survival Screen to Identify Chemoradiation Sensitizers.
|
Academic Article
|
Care Patterns for Stereotactic Radiosurgery in Small Cell Lung Cancer Brain Metastases.
|
Academic Article
|
Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.
|
Academic Article
|
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
|
Academic Article
|
Simple oligonucleotide-based multiplexing of single-cell chromatin accessibility.
|
Academic Article
|
Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.
|
Academic Article
|
The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis.
|
Academic Article
|
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.
|
Academic Article
|
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
|
Academic Article
|
A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases.
|
Academic Article
|
Expert consensus on perioperative treatment for non-small cell lung cancer.
|
Academic Article
|
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer.
|
Academic Article
|
Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy.
|
Academic Article
|
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.
|
Academic Article
|
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.
|
Academic Article
|
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer.
|
Academic Article
|
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
|
Academic Article
|
Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions.
|
Academic Article
|
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
|
Academic Article
|
Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology.
|
Academic Article
|
Statin Use and Chemoradiation in Esophageal Squamous Cell Carcinomas: Ready for Prime Time?
|
Academic Article
|
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
|
Academic Article
|
Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models.
|
Academic Article
|
Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial.
|
Academic Article
|
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma.
|